SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.

Autor: Di Mambro A; School of Life and Health Sciences, University of Roehampton, London, UK., Arroyo-Berdugo Y; School of Life and Health Sciences, University of Roehampton, London, UK., Fioretti T; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy., Randles M; Chester Centre for Leukaemia Research, Chester Medical School, University of Chester, Chester, UK., Cozzuto L; Centre Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rajeeve V; Barts Cancer Institute, Queen Mary University of London, London, UK., Cevenini A; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy., Austin MJ; Barts Cancer Institute, Queen Mary University of London, London, UK., Esposito G; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy., Ponomarenko J; Centre Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; University Pompeu Fabra (UPF), Barcelona, Spain., Lucas CM; Chester Centre for Leukaemia Research, Chester Medical School, University of Chester, Chester, UK., Cutillas P; Barts Cancer Institute, Queen Mary University of London, London, UK., Gribben J; Barts Cancer Institute, Queen Mary University of London, London, UK., Williams O; Great Ormond Street Institute of Child Health London, UCL, London, UK., Calle Y; School of Life and Health Sciences, University of Roehampton, London, UK., Patel B; Barts Cancer Institute, Queen Mary University of London, London, UK., Esposito MT; School of Life and Health Sciences, University of Roehampton, London, UK. mariateresa.esposito@surrey.ac.uk.; School of Biosciences, University of Surrey, Guildford, UK. mariateresa.esposito@surrey.ac.uk.

Publikováno v: Oncogene [Oncogene] 2023 Dec; Vol. 42 (50), pp. 3670-3683. Date of Electronic Publication: 2023 Oct 27.

A simulation model estimates lifetime health and economic outcomes of screening prediabetes using the 1-h plasma glucose.

Autor: Andellini M; Health Technology Assessment Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Manco M; Research Area for Multifactorial Diseases and Complex Phenotypes. Bambino Gesù Children's Hospital, IRCCS, Via F. Baldelli 38, 00146, Rome, Italy. melania.manco@opbg.net., Esposito MT; Health Technology Assessment Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Tozzi AE; Research Area for Multifactorial Diseases and Complex Phenotypes. Bambino Gesù Children's Hospital, IRCCS, Via F. Baldelli 38, 00146, Rome, Italy., Bergman M; NYU Grossman School of Medicine, NYU Diabetes Prevention Program, Division of Endocrinology, Diabetes, Metabolism, VA New York Harbor Healthcare System, Manhattan Campus, New York, NY, 10010, USA., Ritrovato M; Health Technology Assessment Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Publikováno v: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 9-17. Date of Electronic Publication: 2022 Sep 20.

Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy.

Autor: Roy NK; Case Western Reserve University, Cleveland, OH, United States.; La Jolla Institute for Immunology, San Diego, CA, United States., Tewari D; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India., Esposito MT; School of Life and Health Science University of Roehampton, Roehampton, United Kingdom.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2022 Aug 30; Vol. 13, pp. 988226. Date of Electronic Publication: 2022 Aug 30 (Print Publication: 2022).

Characterization of stem cell landscape and assessing the stemness degree to aid clinical therapeutics in hematologic malignancies.

Autor: Feng, Yuan-dong¹ (AUTHOR), Du, Jin² (AUTHOR), Chen, Hong-li¹ (AUTHOR), Shen, Ying¹ (AUTHOR), Jia, Ya-chun¹ (AUTHOR), Zhang, Peng-yu¹ (AUTHOR), He, Aili¹ (AUTHOR), Yang, Yun¹ (AUTHOR) yangyun108@mail.xjtu.edu.cn

Publikováno v: Scientific Reports. 10/10/2024, Vol. 14 Issue 1, p1-21. 21p.

Immersive Virtual Reality Medical Simulation: Autonomous Trauma Training Simulator.

Autor: Couperus K; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA., Young S; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA., Walsh R; Emergency Medicine, Vanderbilt University Medical Center, Nashville, USA., Kang C; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA.; Emergency Medicine, University of Washington, Seattle, USA.; Military/Emergency Medicine, Uniformed Services University of the Health Sciences, Bethesda, USA.; College of Medicine, Baylor University, Houston, USA., Skinner C; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA., Essendrop R; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA., Fiala K; Emergency Medicine, Darnall Army Medical Center, Fort Hood, USA., Phelps JF; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA., Sletten Z; Emergency Medicine, San Antonio Military Medical Center, San Antonio, USA., Esposito MT; Emergency Medicine, San Antonio Military Medical Center, San Antonio, USA., Bothwell J; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA., Gorbatkin C; Emergency Medicine, Madigan Army Medical Center, Tacoma, USA.

Publikováno v: Cureus [Cureus] 2020 May 11; Vol. 12 (5), pp. e8062. Date of Electronic Publication: 2020 May 11.